EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Target the Heart: A New Axis of Alzheimer’s Disease Prevention

Lawrence I Heller iD, Allison S Lowe, Thaís Del Rosario Hernández iD, Sayali V Gore iD, Mallika Chatterjee iD, Robbert Creton

Journal of Dementia and Alzheimer's Disease · 2025

DOI: 10.3390/jdad2020010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Dementia and Alzheimer's Disease, 2025. Verfasst von Lawrence I Heller und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02912, USA. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH, Fulbright Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: Cyclosporine A and other calcineurin inhibitors have been identified as prospective treatments for preventing Alzheimer’s disease. We previously found that calcineurin inhibitors elicit a unique behavioral profile in zebrafish larvae, characterized by increased activity, acoustic hyperexcitability, and reduced visually guided behaviors. Screening a large library of FDA-approved compounds using Z-LaP Tracker revealed that some heart medications produce a similar behavioral profile, suggesting these drugs may exert calcineurin-inhibitor-like effects relevant to prevent-ing or ameliorating Alzheimer’s disease.

Methods

Screening a large library of FDA-approved drugs using Z-LaP Tracker, a neural network model, revealed a cluster of 65 drugs demonstrating a cyclosporine A-like behavioral profile. Fourteen of these drugs were heart medications, including angiotensin receptor blockers, beta blockers, al-pha-adrenergic receptor antagonists, and a statin.

Results

Dual administration of the heart medications with cyclosporine A in Z-LaP Tracker revealed synergistic effects: lower doses of each heart medication could be delivered in conjunction with a lower dose of cyclosporine A to evoke a similar or larger behavioral effect than higher doses of each drug independently. Other studies have shown that many of these heart medica-tions drugs directly or indirectly inhibit the calcineurin–NFAT pathway, like cyclo-sporine A, providing a potential mechanism.

Conclusions

Co-administering a low dose of cyclosporine A with select cardiac drugs could be a potentially effective treatment strategy for preventing Alzheimer’s disease occurrence and simultaneously treating cardiovascular dysfunction, while mitigating the side effects associated with higher doses of cyclosporine A. Given that heart disease precedes Alzheimer’s disease in many patients, physicians may be able to create a treatment regimen that addresses both con-ditions. Our results suggest that a calcineurin inhibitor combined with simvastatin, irbesartan, cilostazol, doxazosin, or nebivolol is the most promising candidate for future exploration.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseCyclosporine Aagingcardiovascular diseasecilostazoldementiadoxazosinirbesartannebivololsimvastatin

Autor:innen und Institutionen

  • Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02912, USA.
  • Amity Institute of Neuropsychology and Neurosciences, Amity University, Noida 201303, India.

ORCID-Profile: Lawrence I Heller, Thaís Del Rosario Hernández, Sayali V Gore, Mallika Chatterjee

Förderung

  • NIGMS NIH HHS
  • NIH
  • Fulbright Foundation

Zitieren

APA

Heller, L. I., Lowe, A. S., Del Rosario Hernández, T., Gore, S. V., Chatterjee, M., & Creton, R. (2025). Target the Heart: A New Axis of Alzheimer’s Disease Prevention. Journal of Dementia and Alzheimer's Disease. https://doi.org/10.3390/jdad2020010

Vancouver

Heller LI, Lowe AS, Del Rosario Hernández T, Gore SV, Chatterjee M, Creton R. Target the Heart: A New Axis of Alzheimer’s Disease Prevention. Journal of Dementia and Alzheimer's Disease. 2025. doi:10.3390/jdad2020010

BibTeX
@article{Heller2025,
  author = {Heller, Lawrence I and Lowe, Allison S and Del Rosario Hernández, Thaís and Gore, Sayali V and Chatterjee, Mallika and Creton, Robbert},
  title = {Target the Heart: A New Axis of Alzheimer’s Disease Prevention},
  journal = {Journal of Dementia and Alzheimer's Disease},
  year = {2025},
  doi = {10.3390/jdad2020010}
}
Kostenlos starten →